Showing results (491-500 of 902) with videos related to

Sort By:
Pageof 91
Vox Sanguinis|April 16, 2011
The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryoverL Johnson, K M Winter, S Reid, et al.
Therapeutic Advances in Medical Oncology|August 11, 2018
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysisKatrin M Sjoquist, Sarah J Lord, Michael L Friedlander, et al.
International Journal of Cancer|March 18, 2026
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registryPatrick Marschner, Kai Ringwald, Marc Thill, et al.
Clinical Epidemiology|May 7, 2015
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort studyNorbert Marschner, Dirk Arnold, Erik Engel, et al.
Spine|September 11, 2002
A randomized controlled trial of exercise and manipulative therapy for cervicogenic headacheGwendolen Jull, Patricia Trott, Helen Potter, et al.
Biochimie|November 17, 2011
S1 pocket fingerprints of human and bacterial methionine aminopeptidases determined using fluorogenic libraries of substrates and phosphorus based inhibitorsMarcin Poreba, Anna Gajda, Jan Picha, et al.
Transfusion|December 9, 2015
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cellsChristopher A Tormey, Manjula Santhanakrishnan, Nicole H Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|September 17, 2017
Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort studyUlla von Verschuer, Roland Schnell, Hans Werner Tessen, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Photoaffinity labeling of diphtheria toxin fragment A with NAD: structure of the photoproduct at position 148S F Carroll, J A McCloskey, P F Crain, et al.
Urologic Oncology|August 23, 2018
Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-RegistryPeter J Goebell, Lothar Müller, Andreas Hübner, et al.
Pageof 91